Metraipolis › archive › dc_2bf9f404a3aa
Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study — Europe PMC PMID:41749882
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41749882
- DOI
- 10.3390/cancers18040629
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T19:57:47.138Z
- SHA-256 of the archived text
e0f8478bb5fa06e1c0754fc6637f40f1dc762488c3d27f348c5ac470e882ce0e- Stable URL of this page
https://metraipolis.com/documento/dc_2bf9f404a3aa
How to cite
Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study — Europe PMC PMID:41749882 — Europe PMC (en), https://europepmc.org/article/MED/41749882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bf9f404a3aa (Metraipolis archive dc_2bf9f404a3aa, sha256 e0f8478bb5fa06e1c0754fc6637f40f1dc762488c3d27f348c5ac470e882ce0e)
BibTeX
@misc{dc2bf9f404a3aa,
title = {Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study — Europe PMC PMID:41749882},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41749882},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bf9f404a3aa; sha256 e0f8478bb5fa06e1c0754fc6637f40f1dc762488c3d27f348c5ac470e882ce0e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749882. Agents can read the archived copy with the MCP tool read_document.